Company News: Pfizer (PFE) Q1 results beat analysts’ expectations

Market news

3 May 2016

Company News: Pfizer (PFE) Q1 results beat analysts’ expectations

Pfizer reported Q1 FY 2016 earnings of $0.67 per share (versus $0.51 in Q1 FY 2015), beating analysts' consensus of $0.55.

The company's quarterly revenues amounted to $13.005 bln (+19.3% y/y), beating consensus estimate of $12.008 bln.

Pfizer also issued upside guidance for FY 2016, projecting EPS of $2.38-2.48 (versus analysts' consensus of $2.28) and revenues of $51.0-53.0 bln (versus analysts' consensus of $51.31 bln).

PFE rose to $33.68 (+2.68%) in pre-market trading.

Foreign exchange market. European session: the British pound traded lower against the U.S. dollar after the release of the weaker-than-expected manufacturing PMI data from the U.K.

Company News: American International Group (AIG) Q1 earnings miss analysts’ estimates

Market Focus

Material posted here is solely for information purposes and reliance on this may lead to losses. Past performances are not a reliable indicator of future results. Please read our full disclaimer

Open Demo Account & Personal Page

Personal area

support@teletradepartners.com

Risk Warning: Trading in the financial markets (including trading on margin) provides a wide range of opportunities and enables investors ready to take risks to make high profits, but it carries a potentially high level of risk of loss. Therefore, prior to trading you should take into careful consideration whether such operations are suitable for you in terms of your level of knowledge and financial situation.